A detailed history of Prestige Wealth Management Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 59 shares of BMRN stock, worth $3,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
59
Previous 34 73.53%
Holding current value
$3,931
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $1,725 - $2,346
25 Added 73.53%
59 $4,000
Q2 2024

Aug 06, 2024

SELL
$74.43 - $92.22 $1,339 - $1,659
-18 Reduced 34.62%
34 $2,000
Q1 2024

Apr 26, 2024

SELL
$83.81 - $99.0 $5,363 - $6,336
-64 Reduced 55.17%
52 $4,000
Q4 2023

Apr 26, 2024

BUY
$76.22 - $98.51 $457 - $591
6 Added 5.45%
116 $11,000
Q4 2023

Feb 08, 2024

BUY
$76.22 - $98.51 $457 - $591
6 Added 5.45%
116 $11,000
Q3 2023

Apr 26, 2024

SELL
$85.07 - $94.48 $2,296 - $2,550
-27 Reduced 19.71%
110 $9,000
Q3 2023

Nov 13, 2023

SELL
$85.07 - $94.48 $2,296 - $2,550
-27 Reduced 19.71%
110 $9,000
Q1 2023

Apr 26, 2024

BUY
$87.74 - $117.27 $7,457 - $9,967
85 Added 163.46%
137 $13,000
Q1 2023

May 16, 2023

BUY
$87.74 - $117.27 $614 - $820
7 Added 5.38%
137 $13,000
Q4 2022

Feb 07, 2023

BUY
$80.93 - $108.63 $728 - $977
9 Added 7.44%
130 $13,000
Q3 2022

Nov 01, 2022

SELL
$82.16 - $96.94 $8,216 - $9,694
-100 Reduced 45.25%
121 $11,000
Q2 2022

Aug 10, 2022

BUY
$71.48 - $86.85 $5,146 - $6,253
72 Added 48.32%
221 $19,000
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $897 - $1,025
12 Added 8.76%
149 $11,000
Q2 2021

Aug 12, 2021

BUY
$75.51 - $84.79 $1,208 - $1,356
16 Added 13.22%
137 $11,000
Q1 2021

May 13, 2021

SELL
$74.73 - $90.69 $1,419 - $1,723
-19 Reduced 13.57%
121 $9,000
Q4 2020

Feb 17, 2021

BUY
$72.61 - $90.2 $5,300 - $6,584
73 Added 108.96%
140 $12,000
Q3 2020

Oct 26, 2020

SELL
$71.87 - $131.03 $4,312 - $7,861
-60 Reduced 47.24%
67 $5,000
Q2 2020

Aug 13, 2020

BUY
$79.55 - $124.22 $5,091 - $7,950
64 Added 101.59%
127 $16,000
Q1 2020

May 15, 2020

BUY
$71.37 - $96.85 $4,496 - $6,101
63 New
63 $5,000
Q1 2019

Aug 16, 2019

SELL
$84.2 - $98.62 $10,693 - $12,524
-127 Closed
0 $0
Q4 2018

Apr 16, 2019

BUY
$80.14 - $106.07 $10,177 - $13,470
127 New
127 $11,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.